Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.
L L Shears, … , A Lizonova, S M Pham
L L Shears, … , A Lizonova, S M Pham
Published October 15, 1997
Citation Information: J Clin Invest. 1997;100(8):2035-2042. https://doi.org/10.1172/JCI119736.
View: Text | PDF
Research Article

Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.

  • Text
  • PDF
Abstract

Research Article

Authors

L L Shears, N Kawaharada, E Tzeng, T R Billiar, S C Watkins, I Kovesdi, A Lizonova, S M Pham

×

Total citations by year

Year: 2020 2017 2016 2015 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1995 1994 Total
Citations: 6 4 5 1 2 2 3 3 5 5 5 6 10 11 9 20 24 29 27 10 1 2 190
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2017 (4)

Title and authors Publication Year
Role of inducible nitric oxide synthase in endothelium-independent relaxation to raloxifene in rat aorta: Raloxifene-induced vasorelaxation by iNOS
CM Wong, CL Au, SY Tsang, CW Lau, X Yao, Z Cai, AC Chung
British Journal of Pharmacology 2017
Macrophage-stimulated microRNA expression in mural cells promotes transplantation-induced neointima formation
X Guo, M Sun, C Dai, X Zhang, Q Yin, J Ling, X Li, X Wu, F Jiang, J Wang
Oncotarget 2017
Inducible nitric oxide synthase: Good or bad?
M Lind, A Hayes, M Caprnda, D Petrovic, L Rodrigo, P Kruzliak, A Zulli
Biomedicine & Pharmacotherapy 2017
My Continuing Evolution as a Surgeon-Scientist: A Decade after the Jacobson Promising Investigator Award
E Tzeng
Journal of the American College of Surgeons 2017

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts